Tevogen Bio Warrant (TVGNW)

• Market cap: $8.26M
• 1 day: 0%
• 5 days: 1.81%
• 1 month: -0.44%
• 3 months: -25.91%
• 6 months: -28.84%
• Year to date: -25.17%
• 1 year: 9.51%
• 5 years: -90.02%
• 10 years: -90.02%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17